The clinical usefulness of the measurement of cytokines.
The utilization of accurate and sensitive methods for the measurement of cytokines in body fluids is prerequisite for the proper use of these mediators in clinical practice. Many factors contribute to the complexity of cytokine quantitation. Bioassays historically preceded immunoassays, which are now very popular, but there is a need for standardization. Nevertheless, due to the local effects of cytokines, the study of their blood levels is of limited value for an understanding of the pathophysiology of these mediators. This explains the development of alternative approaches to assess the ability of cells to produce cytokines. These include the Enzyme-Linked Immuno Spot Assay (ELISPOT), the measurement of cell-associated cytokines by flow cytometry, and the study of cytokine secretion by isolated peripheral blood mononuclear cells or by whole blood test. All these techniques, associated with a local detection of cytokines by immunohistochemistry or in situ hybridization and reverse transcriptase polymerase chain reaction, appear to be complementary tools for a better understanding of the biology of cytokines. Selected examples of possible clinical applications related to infectious diseases, cancer, autoimmune diseases, allergy, transplantation and preclinical evaluation of drugs and biotechnology products are given.
Service d'Immunologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. jacques.bienvenu@chu-lyon.fr
J
J
Bienvenu
G
G
Monneret
N
N
Fabien
J P
JP
Revillard
D001826:Body Fluids / Q000737:chemistry; D016207:Cytokines / Q000032:analysis* / Q000097:blood; D003933:Diagnosis; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D020133:Reverse Transcriptase Polymerase Chain Reaction
D016207:Cytokines